Page 29

 In August 2015 , the U.S. Food and Drug Administration ( FDA ) approved Addyi ‘s marketing application. This drug, accidentally developed during the manufacturing process of an antidepressant, claims to improve hypoactive sexual desire disorder ( HSDD ) in women . Considering that many sexual dysfunction medications currently on the market are only for men, pharmaceutical companies and civic groups supporting the drug hailed the FDA ‘s approval as a victory for feminism. However, a number of women’s groups and academics have expressed concerns about the drug’s release. While this drug is widely known as “female Viagra,” seemingly offering a convenient and effective solution to women’s low libido, similar to the benefits Continue reading